Vemurafenib Resistance Collection Mode [2022] Vemurafenib Resistance Collection Mode [2022]

Vemurafenib Resistance

Oct. 5, 2024

A Nexus Consisting of Beta-Catenin and Stat3 Attenuates BRAF Inhibitor Efficacy and Mediates Acquired Resistance to Vemurafenib - ScienceDirect BRAF Inhibitor Resistance in Melanoma: Mechanisms and Alternative Therapeutic Strategies | SpringerLink Vemurafenib resistance increases melanoma invasiveness and modulates the tumor microenvironment by MMP-2 upregulation - ScienceDirect Vemurafenib Resistance

Potential mechanisms of acquired-resistance to vemurafenib. Two major... | Download…
Proposed mechanism of vemurafenib resistance. In the presence of BRAF... | Download…
The role of microRNAs in response and resistance to vemurafenib in... | Download Sc…
Resistance to RAF Inhibitors Revisited - ScienceDirect
Representation of the resistance mechanisms to the vemurafenib. (a)... | Download S…
Frontiers | Diverse Mechanisms of BRAF Inhibitor Resistance in Melanoma Identified …
Resistance mechanisms to targeted therapy in BRAF-mutant melanoma - A mini review -…
HI-511 overcomes melanoma drug resistance via targeting AURKB and BRAF V600E
CHMFL-BMX-078, a BMX inhibitor, overcomes the resistance of melanoma to vemurafenib…
Adaptive resistance of melanoma cells to RAF inhibition via reversible induction of…
A Nexus Consisting of Beta-Catenin and Stat3 Attenuates BRAF Inhibitor Efficacy and…
BRAF Inhibitor Resistance in Melanoma: Mechanisms and Alternative Therapeutic Strat…
Vemurafenib resistance increases melanoma invasiveness and modulates the tumor micr…
Mechanisms of resistance to BRAF inhibitors. A, gray rectangle: mutant... | Downloa…
PDF] Resistance to BRAF inhibitors: unraveling mechanisms and future treatment opti…
Modelling vemurafenib resistance in melanoma reveals a strategy to forestall drug r…
Adaptive resistance to RAF inhibitors in melanoma - Kugel - 2014 - Pigment Cell & M…
Emerging Drug Combination Approaches in Melanoma Therapy | IntechOpen
PDF] Acquired resistance to targeted MAPK inhibition in melanoma | Semantic Scholar
Vemurafenib resistance in melanoma cells lacking USP28. Under normal... | Download …
IJMS | Free Full-Text | Targeted Therapy in Melanoma and Mechanisms of Resistance
Figure 2 from Vemurafenib: an evidence-based review of its clinical utility in the …
Researchers Visualize Resistant Cancer Cells - Penn Bioengineering Blog
Cancers | Free Full-Text | Adaptive Responses as Mechanisms of Resistance to BRAF I…
Emerging Drug Combination Approaches in Melanoma Therapy | IntechOpen
Cells | Free Full-Text | Evolving Acquired Vemurafenib Resistance in a BRAF V600E M…
Phyto-sesquiterpene lactones DET and DETD-35 induce ferroptosis in vemurafenib sens…
Cancers | Free Full-Text | Adaptive Responses as Mechanisms of Resistance to BRAF I…
Increased inflammatory lipid metabolism and anaplerotic mitochondrial activation fo…
Synergistic effects of vemurafenib and fingolimod (FTY720) in vemurafenib‑ resistant…
Molecules | Free Full-Text | Identification of Dihydrolipoamide Dehydrogenase as Po…
Identification of vemurafenib-resistance genes using MAGeCK. The sgRNA... | Downloa…
Frontiers | Resistance mechanisms in BRAFV600E paediatric high-grade glioma and cur…
Dissecting therapeutic resistance to RAF inhibition in melanoma by tumor genomic pr…
Comparison of the vemurafenib-resistant A375 melanoma cell lines to... | Download S…
Reversing vemurafenib‐resistance in primary melanoma cells by combined romidepsin a…
Eradicating tumor drug resistance at its YAP‐biomechanical roots | The EMBO Journal
Increased inflammatory lipid metabolism and anaplerotic mitochondrial activation fo…
Cancers | Free Full-Text | Mechanisms of Acquired BRAF Inhibitor Resistance in Mela…
ACY-1215 accelerates vemurafenib induced cell death of BRAF-mutant melanoma cells v…
Loss of BOP1 confers resistance to BRAF kinase inhibitors in melanoma by activating…
Concurrent MEK and autophagy inhibition is required to restore cell death associate…
Mechanisms of acquired resistance displayed by vemurafenib-resistant... | Download …
Pharmaceutics | Free Full-Text | Targeting BRAF Activation as Acquired Resistance M…
Synergistic effects of vemurafenib and fingolimod (FTY720) in vemurafenib‑ resistant…
Figure 1 from MEK ERK CRAF Tumor growth Tumor progression Tumor regression Tumor gr…
Frontiers | The Tubulin Inhibitor VERU-111 in Combination With Vemurafenib Provides…
Vemurafenib-resistant cells display enhanced MAPK pathway activation. A... | Downlo…
BRAF Inhibitor Resistance in Melanoma: Mechanisms and Alternative Therapeutic Strat…
V600E BRAF -mutant melanoma becomes resistant to vemurafenib. A,... | Download Scie…
Biomedicines | Free Full-Text | Melanoma Cell Resistance to Vemurafenib Modifies In…
Vemurafenib: the first drug approved for BRAF-mutant cancer | Nature Reviews Drug D…
Serial dose-response curves showing generation of acquired vemurafenib... | Downloa…
IF4E has a key role in vemurafenib resistance in A375 BRAFV600E human... | Download…
DELAYING DRUG RESISTANCE AND PROLONGING SURVIVAL IN MELANOMA – Sanguine Bio Researc…
Cancers | Free Full-Text | Adaptive Responses as Mechanisms of Resistance to BRAF I…
BRAF inhibitor resistance of melanoma cells triggers increased susceptibility to na…
IJMS | Free Full-Text | Role Played by Signalling Pathways in Overcoming BRAF Inhib…
POU4F1 promoted the resistance of melanoma cells to Vemurafenib. a The... | Downloa…
IJMS | Free Full-Text | Characterization of Vemurafenib-Resistant Melanoma Cell Lin…
A) acquired resistance of isolated A375 cells to Vemurafenib. (B)... | Download Sci…
Resistance mechanisms to targeted therapy in BRAF-mutant melanoma - A mini review -…
Effect of acquired resistance to BRAF inhibition by vemurafenib on cell... | Downlo…
IJMS | Free Full-Text | The Sphingosine Kinase 2 Inhibitor ABC294640 Restores the S…
Vemurafenib (RG67204, PLX4032): a potent, selective BRAF kinase inhibitor | Future …
IC50 in Vemurafenib-resistant A375 and SK-Mel-28 cells.... | Download Scientific Di…
ZEB1‐mediated melanoma cell plasticity enhances resistance to MAPK inhibitors | EMB…
Vemurafenib resistant melanoma cells exhibit Mcl-1 overexpression. A.... | Download…
IJMS | Free Full-Text | Strategies for Overcoming Resistance in Tumours Harboring B…
Oncogene Mimicry as a Mechanism of Primary Resistance to BRAF Inhibitors - ScienceD…
Degradation of AMPK‐α1 sensitizes BRAF inhibitor‐resistant melanoma cells to argini…
MAPK (A) and RAS (B) signaling proteins in vemurafenib resistance.... | Download Sc…
A Novel Aptamer LL4A Specifically Targets Vemurafenib-Resistant Melanoma through Bi…
Mechanisms of acquired resistance to targeted cancer therapies | Future Oncology
Targeted therapies and resistance for melanoma. (A) This panel depicts... | Downloa…
Challenging resistance mechanisms to therapies for metastatic melanoma: Trends in P…
Vemurafenib resistance reprograms melanoma cells towards glutamine dependence | Jou…
Managing Side Effects of Vemurafenib Therapy for Advanced Melanoma. - Abstract - Eu…
BRAF inhibitor resistance of melanoma cells triggers increased susceptibility to na…
Mechanisms and strategies to overcome resistance to molecularly targeted therapy fo…
Resistance to vemurafenib is associated with the reestablishment of... | Download S…
Vemurafenib resistance reprograms melanoma cells towards glutamine dependence | Jou…
Involvement of HMGB1 in vemurafenib resistance in thyroid cancer cells harboring BR…
EGFR/uPAR interaction as druggable target to overcome vemurafenib acquired resistan…
Rapid signaling reactivation after targeted BRAF inhibition predicts the proliferat…
Resveratrol Overcomes Cellular Resistance to Vemurafenib Through Dephosphorylation …
Clinical Development of BRAF plus MEK Inhibitor Combinations: Trends in Cancer
Frontiers | Functional Genomic Screening Independently Identifies CUL3 as a Mediato…
Proposed mechanism of vemurafenib resistance. In the presence of BRAF... | Download…
Overcoming Resistance to Targeted Anticancer Therapies through Small-Molecule-Media…
Phyto-sesquiterpene lactones DET and DETD-35 induce ferroptosis in vemurafenib sens…
Figures and data in RNF43 inhibits WNT5A-driven signaling and suppresses melanoma i…
Modelling vemurafenib resistance in melanoma reveals a strategy to forestall drug r…
RSK2 induces vemurafenib resistance through upregulating cyclin D1... | Download Sc…
Vemurafenib resistance reprograms melanoma cells towards glutamine dependence | Jou…
Resistance to BRAF Drugs In Melanoma may be Overcome by Blocking Autophagy With Mal…
Paradox-Breaking RAF Inhibitors that Also Target SRC Are Effective in Drug- Resistan…
Original Article Targeting STAT3 restores BRAF inhibitor sensitivity through miR-75…
Dose-response curves of paired parental/vemurafenib-resistant melanoma... | Downloa…
Link 1 | Link 2 | Link 3 | Link 4 | Link 5 | Link 6 |